Back

Prevalence and risk of DOACs inappropriate dosing in atrial fibrillation. An analysis of the Swiss-AF and BEAT-AF registries

1 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 2 - Drug treatment for atrial fibrillation Oral Anticoagulation ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Giulia Montrasio

Kantonsspital Aarau, Aarau (Switzerland)

9 More presentations in this session

Presentation thumbnail
Doctor W. Amara (Le Raincy-Montfermeil, FR)
Abstract
Presentation thumbnail
Doctor M. Mihajlovic (Belgrade, RS)
Abstract Slides
Presentation thumbnail
Associate Professor M. Harada (Toyoake, JP)
Abstract
Presentation thumbnail
Doctor O. Hajas (Debrecen, HU)
Abstract Slides
Presentation thumbnail
Professor H. Crijns (Maastricht, NL)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Drug treatment for atrial fibrillation

The Event

Event poster

ESC Congress 2019

1 September 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Prevalence and predictors of inappropriate DOAC prescription on first attendance at a dedicated atrial fibrillation clinic
27 August 2021
thumbnail
Congress Presentation
Non-vitamin K antagonist oral anticoagulants (NOACs) versus vitamin K antagonists (VKAs) in (morbidly) obese or low body weight patients with atrial fibrillation: a meta-analysis
23 April 2021
thumbnail
Congress Presentation
Apixaban 2.5 mg twice daily is effective and safe for patients with atrial fibrillation and combinations of advanced age, low body weight, and elevated creatinine: insights from ARISTOTLE
2 September 2019
thumbnail
Congress Presentation
Incidence of cardiovascular events in patients with atrial fibrillation anticoagulated with rivaroxaban after 2.5 years of follow-up: not all is stroke or bleeding
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources